Skip to main content
. 2021 Nov 25;7(2):152–164. doi: 10.1016/j.ekir.2021.11.003

Figure 2.

Figure 2

Contraceptive options and considerations for adolescent females with kidney disease. (Adapted from Ahmed et al.,82 Attini et al.,115 Sachdeva,101Watnick,104 and Wiles and Lightstone102). CVD, cardiovascular disease; DM, diabetes mellitus; HTN, hypertension; N/A, not available; SLE, systemic lupus erythematosus; VTE, venous thromboembolism.